Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02871596 · ClinicalTrials.gov registry record · NA
Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds
A NA study of Healthy, sponsored by Pharmanex.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT02871596: Completed NA study of Healthy, sponsored by Pharmanex.
NCT02871596 is a NA study of Healthy that has completed, run by Pharmanex. The registered enrollment target is 27 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02871596, a NA study of Healthy, has completed, sponsored by Pharmanex.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine the effects of both an anthocyanin-rich polyphenol blend and an anthocyanin-rich polyphenol blend combined with a prebiotic blend on fecal microbiota metabolism (assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis) and fecal microbiota composition (assessed by next generation sequencing).
Primary Outcome
assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Flavonoids
- DIETARY_SUPPLEMENT Flavonoids+Prebiotics
Study Locations (1)
Utah
- Utah State University - Logan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-02 |
| Phase | NA |
What the finished NCT02871596 record still lists
NCT02871596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02871596 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT02871596 about?
NCT02871596 is a clinical study titled "Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds". The purpose of the study is to determine the effects of both an anthocyanin-rich polyphenol blend and an anthocyanin-rich polyphenol blend combined with a prebiotic blend on fecal microbiota metabolism (assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis) and fecal microbiot...
What is the current status of trial NCT02871596?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-08. Estimated completion is 2017-02.
What conditions does trial NCT02871596 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT02871596?
The interventions under investigation include: Placebo (OTHER), Flavonoids (DIETARY_SUPPLEMENT), Flavonoids+Prebiotics (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02871596?
This trial is sponsored by Pharmanex, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02871596 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02871596's enrollment target sits among peer trials
27 752nd of 1090 higher than 332 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia